Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Using insulin in type 2 diabetes: in need of a renaissance?

× No keyword cloud information.

22 in total

1. Prandial insulin substitution with insulin lispro or insulin lispro mid mixture vs. basal therapy with insulin glargine: a randomized controlled trial in patients with type 2 diabetes beginning insulin therapy.

Authors: Christof Kazda; Hiltrud Hülstrunk; Karin Helsberg; Frank Langer; Thomas Forst; Markolf Hanefeld
Journal: J Diabetes Complications Date: 2006 May-Jun Impact factor: 2.852

2. Starting insulin therapy in type 2 diabetes: twice-daily biphasic insulin Aspart 30 plus metformin versus once-daily insulin glargine plus glimepiride.

Authors: P H Kann; T Wascher; V Zackova; J Moeller; J Medding; A Szocs; M Mokan; F Mrevlje; M Regulski
Journal: Exp Clin Endocrinol Diabetes Date: 2006-10 Impact factor: 2.949

3. Nice insulins, pity about the evidence.

Authors: F Holleman; E A M Gale
Journal: Diabetologia Date: 2007-09 Impact factor: 10.122

4. A comparison of intensive mixture therapy with basal insulin therapy in insulin-naïve patients with type 2 diabetes receiving oral antidiabetes agents.

Authors: S J Jacober; J L Scism-Bacon; A J Zagar
Journal: Diabetes Obes Metab Date: 2006-07 Impact factor: 6.577

5. Twice-daily pre-mixed insulin rather than basal insulin therapy alone results in better overall glycaemic control in patients with Type 2 diabetes.

Authors: J K Malone; S Bai; B N Campaigne; J Reviriego; B Augendre-Ferrante
Journal: Diabet Med Date: 2005-04 Impact factor: 4.359

6. Combined therapy with insulin lispro Mix 75/25 plus metformin or insulin glargine plus metformin: a 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapy.

Authors: James K Malone; Lisa F Kerr; Barbara N Campaigne; Richard A Sachson; John H Holcombe
Journal: Clin Ther Date: 2004-12 Impact factor: 3.393

7. Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs.

Authors: Philip Raskin; Elsie Allen; Priscilla Hollander; Andrew Lewin; Robert A Gabbay; Peter Hu; Bruce Bode; Alan Garber
Journal: Diabetes Care Date: 2005-02 Impact factor: 19.112

8. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.

Authors: David C Robbins; Paul J Beisswenger; Antonio Ceriello; Ronald B Goldberg; Robert G Moses; Emmanuil M Pagkalos; Zvonko Milicevic; Cate A Jones; Samiha Sarwat; Meng H Tan
Journal: Clin Ther Date: 2007-11 Impact factor: 3.393

9. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors: D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal: N Engl J Med Date: 1993-09-30 Impact factor: 91.245

10. Advancing insulin therapy in type 2 diabetes previously treated with glargine plus oral agents: prandial premixed (insulin lispro protamine suspension/lispro) versus basal/bolus (glargine/lispro) therapy.

Authors: Julio Rosenstock; Andrew J Ahmann; Gildred Colon; Jamie Scism-Bacon; Honghua Jiang; Sherry Martin
Journal: Diabetes Care Date: 2007-10-12 Impact factor: 19.112